 |
|
 |
Matthew D. Harman, PharmD, MPH |
|
|
 |
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP |
|
|
 |
Gary A. Puckrein, PhD |
|
|
 |
Drake Reiter, PharmD |
ManagedCareCGM.com Presents: Innovations in rtCGM to Improve Clinical Outcomes in Diabetes
| EXPERT FACULTY | ||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
Target Audience
This activity is designed to meet the educational needs of medical directors, registered nurses, pharmacy directors, clinical pharmacists, specialty pharmacists, quality directors, as well as network physicians affiliated with various MCOs, health systems, and other payer organizations.
Statement of Need/Program Overview
Continuous glucose monitoring (CGM) offers immediate assessment of glucose levels and trends. CGMs can provide alerts when glucose levels exceed low or high thresholds or are changing rapidly, allowing patients to adjust insulin dosing or consume carbohydrates to minimize the risk of hypoglycemia. CGM technology also offers key insights for clinicians—including pharmacy professionals—and offers an opportunity for enhanced patient engagement and lifestyle modification. Professional organizations continue to expand recommendations supporting CGM use in patient care protocols in a broader population of patients with type 1, type 2, and gestational diabetes. Current guidelines, emerging clinical evidence, and a presentation of case studies will illustrate the opportunity for real-time CGM (rtCGM) to measurably improve care quality and outcomes for patients with diabetes. Pertinent to managed care decision makers, the discussion will include pharmacy benefit design to improve patient access to rtCGM.
Educational Objectives
After completing this activity, the participant should be better able to:
Accreditation Statement
|
In support of improving patient care, this activity has been planned and implemented by Medical Education Resources (MER) and Impact Education, LLC. MER is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. |
Physician Credit
Medical Education Resources designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Credit
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.5 contact hours.
Medical Education Resources is a provider of continuing nursing education by the California Board of Registered Nursing, Provider #CEP 12299, for 1.5 contact hours.
| Pharmacist Credit | |
 |
Medical Education Resources (MER) designates this continuing education activity for 1.5 contact hours (0.15 CEUs) of the Accreditation Council for Pharmacy Education. Universal Program Number – JA0003680-9999-23-152-H01-P |
DISCLOSURE OF UNLABELED USE
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclosure of Relevant Financial Relationships
Medical Education Resources ensures balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, MER identifies relevant financial relationships with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Reported relevant financial relationships are mitigated by MER to ensure that all scientific research referred to, reported, or used in a CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing learners with high-quality CE activities that promote improvements or quality in health care and not the business interest of an ineligible company.
The authors reported the following financial relationships with ineligible companies whose products or services may be mentioned in this activity:
| Name of Faculty | Reported Financial Relationship |
Gary A. Puckrein, PhD |
Nothing to disclose. |
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP |
Consulting Fees: Sanofi, Lifescan |
Drake Reiter, PharmD |
Nothing to disclose. |
Matthew D. Harman, PharmD, MPH |
Nothing to disclose. |
The content managers reported the following financial relationships with ineligible companies whose products or services may be mentioned in this activity:
| Name of Content Manager | Reported Financial Relationship |
MER Content Managers |
No financial relationships to disclose. |
Impact Education, LLC Staff |
No financial relationships to disclose. |
DISCLAIMER
The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Medical Education Resources, Impact Education, LLC, and/or Dexcom, Inc. The authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.
METHOD OF PARTICIPATION AND REQUEST FOR CREDIT
There are no fees for participating and receiving CME/CE credit for this activity. During the accreditation period, participants must 1) read the learning objectives and faculty disclosures; 2) study the educational activity; 3) and complete the evaluation form. Upon completion of the full CME/CE activity, your certificate will be made available immediately to download and print.
For Pharmacists: Upon successfully completing the activity evaluation form, you may immediately submit your CPE credit to the NABP CPE Monitor Service. This may require you to add or update the e-profile ID/date of birth information saved in your account.
MEDIA
Internet
FEE INFORMATION
There is no fee for this educational activity.